The Gerontological Society of America (GSA), in collaboration with Gerontological Advanced Practice Nurses Association (GAPNA) and AMDA, has launched a new project focused on improving education and awareness of enhanced influenza vaccine products.
- Benefits of Enhanced Influenza Vaccine Products
- More Benefits of Enhanced Influenza Vaccine Products
- Real-World Evidence: What It Says About Enhanced Influenza Vaccine Products
- Practical Strategies for Increasing Use of Enhanced Influenza Vaccine Products Among LTCF Residents and Staff
Featuring Barbara Resnick, PhD, CRNP. Professor in the Department of Organizational Systems and Adult Health at the University of Maryland School of Nursing.
Free Webinar: Understanding the Value of Enhanced Influenza Vaccine Products in Long-Term Care Settings
Thursday, September 17, 2020
1:00 – 2:00 PM ET
Cost: Free for everyone
There are many benefits to preventing flu transmission in long-term care settings yet only about two-thirds of nursing home residents receive annual influenza vaccinations—one of the best known preventive strategies. The COVID-19 pandemic has further amplified the need for effective infection control in these settings. Compared with standard-dose influenza vaccines, enhanced influenza vaccines are not only more effective in preventing disease in older adults, they also provide a higher return on investment. This webinar is designed to help nursing home administrators, infection control teams, and other long-term care staff to (1) understand the benefits of using enhanced influenza vaccine products in residents and (2) learn practical tips that can help leadership and staff consistently apply immunization practices.
- R. Gordon Douglas, MD, Chair, National Adult Vaccination Program Workgroup; Professor Emeritus, Weill Cornell Medical College (Moderator)
- David H. Canaday, MD, Professor of Medicine, Case Western Reserve University; Associate Director, Geriatric, Research, Education, and Clinical Center (GRECC), Louis Stokes Cleveland VA Medical Center; Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center
- Sherry A. Greenberg, PhD, RN, GNP-BC, FGSA, FAANP, FAAN, Associate Professor, Seton Hall University College of Nursing; President-Elect, Gerontological Advanced Practice Nurses Association
- Barbara Resnick, PhD, RN, CRNP, FAAN, FAANP, Professor, University of Maryland School of Nursing; Co-Director, Biology and Behavior Across the Lifespan Organized Research Center; Sonya Ziporkin Gershowitz Chair in Gerontology
This program was jointly developed by GSA, the Gerontological Advanced Practice Nurses Association, and AMDA – The Society for Post-Acute and Long-Term Care Medicine, with support from Sanofi.